Banco Santander S.A. decreased its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 7.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 79,777 shares of the pharmacy operator’s stock after selling 6,203 shares during the period. Banco Santander S.A.’s holdings in Walgreens Boots Alliance were worth $3,650,000 at the end of the most recent quarter.
Other large investors have also recently modified their holdings of the company. Islay Capital Management LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth about $29,000. Americana Partners LLC purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth about $29,000. Private Ocean LLC purchased a new stake in Walgreens Boots Alliance during the first quarter worth about $25,000. West Bancorporation Inc. purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth about $39,000. Finally, Pacifica Partners Inc. purchased a new stake in Walgreens Boots Alliance during the fourth quarter worth about $42,000. 58.03% of the stock is currently owned by institutional investors and hedge funds.
Shares of NASDAQ:WBA traded down $0.15 during trading on Friday, reaching $39.60. The stock had a trading volume of 3,378,765 shares, compared to its average volume of 7,383,946. The business has a fifty day moving average price of $42.22 and a 200-day moving average price of $51.33. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 1.34. The stock has a market cap of $34.87 billion, a P/E ratio of 6.87, a PEG ratio of 1.83 and a beta of 0.55. Walgreens Boots Alliance Inc has a fifty-two week low of $36.65 and a fifty-two week high of $64.50.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, April 2nd. The pharmacy operator reported $1.52 earnings per share for the quarter, beating analysts’ consensus estimates of $1.46 by $0.06. The business had revenue of $35.82 billion during the quarter, compared to analyst estimates of $35.24 billion. Walgreens Boots Alliance had a net margin of 2.52% and a return on equity of 21.26%. The company’s revenue was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.64 earnings per share. As a group, equities analysts forecast that Walgreens Boots Alliance Inc will post 5.53 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Wednesday, May 20th will be given a $0.4575 dividend. This represents a $1.83 dividend on an annualized basis and a dividend yield of 4.62%. The ex-dividend date of this dividend is Tuesday, May 19th. Walgreens Boots Alliance’s dividend payout ratio is presently 30.55%.
A number of research firms recently commented on WBA. Barclays decreased their price objective on shares of Walgreens Boots Alliance from $60.00 to $50.00 and set an “equal weight” rating on the stock in a report on Friday, April 3rd. UBS Group upgraded shares of Walgreens Boots Alliance from a “sell” rating to a “neutral” rating and cut their target price for the stock from $49.00 to $44.00 in a research report on Monday, April 6th. BidaskClub cut shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Friday, May 15th. Cowen cut their target price on shares of Walgreens Boots Alliance from $54.00 to $48.00 and set a “market perform” rating for the company in a research report on Tuesday. Finally, Wells Fargo & Co restated a “hold” rating on shares of Walgreens Boots Alliance in a research report on Thursday, April 2nd. Four analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $51.21.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.